By: P.T., STA
Salus, a distributor of medicines, reported revenue rising by 14% to EUR 458.3 million in 2021. Net profit was up by 28% to EUR 13 million in what the management described as a record year.
Operating profit rose by nearly a quarter to EUR 15.3 million, with EBITDA up by almost 22% to EUR 19.7 million, show consolidated results. Salus’s figures show the Slovenian medicines and food supplements market grew by almost 6% last year in value terms, as the share of more expensive drugs increases.